Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
833.00    4.00 (0.48%)
Bid:
833.00
Ask:
835.00
Spread: 2.00 (0.24%)
Market Cap: £786.55m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Oct 2022 07:00

RNS Number : 7235C
Polar Capital Holdings PLC
13 October 2022
 

13 October 2022 Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides a quarterly update of its unaudited statement of Assets under Management ("AuM").

 

 

Group AuM (unaudited)

 

Polar Capital reports that as at 30 September 2022 its AuM were £18.8bn compared to £18.9bn at the end of the June quarter and £22.1bn at the end of March 2022. During the six-month period, AuM decreased by net redemptions of £0.8bn, outflows from previously reported fund closures of £0.5bn and a £2.0bn decrease related to market movement and fund performance.

 

AuM movement in six months to 30 September 2022

Open ended

funds

Investment

Trusts

Segregated mandates

Total

AuM at 1 April 2022

£16,590m

£4,378m

£1,153m

£22,121m

Net flows

£(753)m

£(62)m

£(30)m

£(845)m

Fund closures1

£(380)m

-

£(79)m

£(459)m

Market movement

and performance

£(1,374)m

£(611)m

£(66)m

£(2,051)m

Total AuM at

30 September 2022

£14,083m

£3,705m

£978m

£18,766m

1 Return of funds to investors on closure of the Phaeacian mutual funds and related segregated mandate in Q1.

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits due to the Group (after the deduction of staff interests) as a product of accrued performance fees in funds managed by the Group three months before the strike point of such performance fee receipts. The majority of the Group's performance fees crystallise in the second half of the financial year. There is no certainty that the fees will be sustained over the next quarter, as performance fees can be volatile.

 

Performance fees

net of staff allocations

Six months to

30 Sept 21

Year to

31 Mar 22

(year-end)

Six months to

30 Sept 22

Received

-

£4.1m

-

Accrued but not yet earned in funds with year ends on or before the financial year end

£2m

n/a

£4.8m*

Total net performance fee profits

£2m

£4.1m

£4.8m*

\* The figures have been reduced by £1.0m of net performance fee distributions that relate to prior accounting periods that IFRS require to be deducted from this year's receipts.

 

 

Gavin Rochussen, Chief Executive, commented:

 

"There has been continued demand and inflows into the Global Insurance, Biotechnology, Healthcare Blue Chip, Smart Energy, European ex-UK Income, Emerging Market Stars, Forager and Global Absolute Return Funds, with combined net inflows of £260m across these funds in the quarter.

 

"A combination of the bear market sell-off, net outflows, fund closures and fund performance meant that our AuM at the end of the six-month period were £18.8bn compared to £18.9bn at the end of the previous quarter and £22.1bn at the end of March 2022. Total net outflows for the quarter were £529m.

 

"During the quarter, the rate of outflows from the open-ended Technology funds continued to decline, with £252m of outflows compared to £380m in the previous quarter and £630m in the first quarter of this calendar year. Outflows of £250m from the UK Value Opportunities Fund during the quarter reflected client asset allocation decisions with UK equity exposure being reduced.

 

"Despite the challenging back drop, we are pleased with the continuing progress in diversifying the business. The Smart funds managed by the Sustainable Thematic team have now collectively reached £150m. The Emerging Market Stars team have had success in the US with the Emerging Market Stars Mutual Fund raising its first £50m.

 

"The well-established Polar Capital Global Insurance fund has continued to deliver robust performance with net inflows of £257m in the six months. The team's low appetite for catastrophe risk has protected investor returns with the Fund well positioned to benefit from ongoing premium rate rises in commercial insurance and a recent acceleration in reinsurance pricing. For the calendar year to September 2022, the fund has achieved absolute positive performance of 12.2% which is 6.5% ahead of its benchmark.

 

"We remain confident that with our diverse range of differentiated, active specialist fund strategies we are well-positioned to perform for our clients and shareholders over the long term."

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)Samir Ayub (Finance Director)

+44 (0)20 7227 2700

 

Numis Securities Limited - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

Stephen Westgate

 

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

 

 

+44 (0)20 3597 8680

 

Camarco

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEEDFFFAFEA
Date   Source Headline
6th Mar 201412:23 pmRNSAdditional Listing
16th Jan 20147:00 amRNSAUM Update
2nd Jan 20148:30 amRNSTotal Voting Rights
19th Dec 20133:31 pmRNSIssue of Equity
18th Dec 201312:16 pmRNSHalf Yearly Report Replacement
17th Dec 20132:36 pmRNSAnnual Financial Report
4th Dec 20137:00 amRNSInterim Results
14th Nov 201312:00 pmRNSNotice of Interim Results
17th Oct 20137:00 amRNSAUM Update
4th Oct 20137:00 amRNSHolding(s) in Company
1st Oct 20137:00 amRNSTotal Voting Rights
30th Sep 20135:44 pmRNSAdditional Listing
30th Sep 20135:36 pmRNSIssue of Equity
25th Sep 20137:00 amRNSIssue of Equity
20th Sep 20134:15 pmRNSHolding(s) in Company
17th Sep 20131:55 pmRNSAdditional Listing
2nd Sep 20133:12 pmRNSHolding(s) in Company
2nd Sep 20132:59 pmRNSTotal Voting Rights
23rd Aug 20133:15 pmRNSAdditional Listing
1st Aug 20131:23 pmRNSTotal Voting Rights
23rd Jul 20135:48 pmRNSResult of AGM
23rd Jul 20137:00 amRNSIssue of Equity
18th Jul 20135:29 pmRNSHolding(s) in Company
11th Jul 20137:00 amRNSAUM Update
5th Jul 20133:20 pmRNSGrant of Share Options
4th Jul 20135:37 pmRNSHolding(s) in Company
1st Jul 20139:16 amRNSTotal Voting Rights
28th Jun 20139:44 amRNSIssue of Equity
21st Jun 201311:07 amRNSAnnual Financial Report
14th Jun 20137:00 amRNSPreliminary Results
22nd May 201311:45 amRNSNotice of Preliminary Results
20th May 20137:00 amRNSIntention to Launch a Global Investment Trust
16th Apr 20137:00 amRNSAdditional Listing
11th Apr 20137:00 amRNSAUM Update
11th Apr 20137:00 amRNSHolding(s) in Company
2nd Apr 20133:51 pmRNSHolding(s) in Company
2nd Apr 20137:00 amRNSTotal Voting Rights
28th Mar 201310:33 amRNSHolding(s) in Company
28th Mar 201310:21 amRNSHolding(s) in Company
28th Mar 20139:19 amRNSIssue of Equity
12th Mar 20133:55 pmRNSHolding(s) in Company
12th Mar 20133:55 pmRNSDirectors' Dealings
12th Mar 20133:55 pmRNSHolding(s) in Company
12th Mar 20133:55 pmRNSHolding(s) in Company
11th Jan 20137:00 amRNSAUM Update
8th Jan 20131:12 pmRNSHolding(s) in Company
31st Dec 20129:40 amRNSTotal Voting Rights
18th Dec 201210:23 amRNSHalf Yearly Report
12th Dec 20127:00 amRNSAdditional Listing
7th Dec 20127:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.